首页 > 最新文献

Clinical and Investigative Medicine最新文献

英文 中文
Analysis of the impact of SARS-CoV-2 infection on immune function and metabolic changes in college students. SARS-CoV-2感染对大学生免疫功能及代谢变化的影响分析
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 DOI: 10.3138/CIM-2025-0009
Fengzhi Li, Yijin Zan, Yukun Cao, Fan Liu, Bingxin Si, Qingling Zhang, LeLa Lin, Jing Guo, Dong Wang, Xianrong Xu

Background: The long-term immune and metabolic effects of COVID-19 in vaccinated populations remain incompletely characterized. This study aimed to analyze dynamic changes in lymphocyte subpopulations (T, B, and Natural Killer [NK] cells [TBNK]) and key metabolic indicators among college students post-Omicron infection with prior vaccination.

Methods: A prospective observational cohort of 71 male students infected with the Omicron variant of COVID-19 (Beijing, China; March-April 2022) and 18 uninfected controls was followed for 2 years. TBNK subsets and metabolic parameters (uric acid, lipid profiles, β2-microglobulin) were analyzed at 3, 6, 12, and 24 months post-infection.

Results: Immunologically, total lymphocytes were elevated at 3 months when compared with controls (P = 0.0063). Total T cells declined at 6 and 12 months but rebounded by 24 months (P < 0.0001). NK cells increased until 12 months, then declined (P < 0.0001). B cells decreased persistently (P < 0.05). Metabolically, uric acid and lipid parameters (total cholesterol, LDL-C, lipoprotein [a]) showed significant fluctuations, with notable increases at 1 year post-infection (P < 0.05). β2-microglobulin levels decreased significantly over time (P < 0.0001).

Conclusion: Omicron infection induces immune and metabolic disturbances lasting at least 1 year, with gradual but incomplete recovery by 2 years. The interplay between immune dysregulation and metabolic alterations may contribute to the long-term health effects of COVID-19. Monitoring both lymphocyte and metabolic dynamics may guide the long-term management of post-COVID-19 sequelae.

背景:COVID-19在接种疫苗人群中的长期免疫和代谢影响尚未完全确定。本研究旨在分析先前接种过omicron疫苗的大学生感染后淋巴细胞亚群(T、B和自然杀伤[NK]细胞[TBNK])和关键代谢指标的动态变化。方法:对71名感染新冠病毒欧米克隆变异的男学生(中国北京,2022年3月- 4月)和18名未感染的对照组进行为期2年的前瞻性观察。在感染后3、6、12和24个月分析TBNK亚群和代谢参数(尿酸、脂质谱、β2-微球蛋白)。结果:免疫方面,与对照组相比,3个月时总淋巴细胞升高(P = 0.0063)。总T细胞在6个月和12个月下降,但在24个月反弹(P < 0.0001)。NK细胞升高至12个月后下降(P < 0.0001)。B细胞持续减少(P < 0.05)。代谢方面,尿酸和脂质参数(总胆固醇、LDL-C、脂蛋白[a])出现显著波动,感染后1年显著升高(P < 0.05)。β2微球蛋白水平随时间显著降低(P < 0.0001)。结论:组粒感染引起至少1年的免疫和代谢紊乱,2年后逐渐恢复,但恢复不完全。免疫失调和代谢改变之间的相互作用可能导致COVID-19对健康的长期影响。监测淋巴细胞和代谢动力学可以指导covid -19后后遗症的长期管理。
{"title":"Analysis of the impact of SARS-CoV-2 infection on immune function and metabolic changes in college students.","authors":"Fengzhi Li, Yijin Zan, Yukun Cao, Fan Liu, Bingxin Si, Qingling Zhang, LeLa Lin, Jing Guo, Dong Wang, Xianrong Xu","doi":"10.3138/CIM-2025-0009","DOIUrl":"10.3138/CIM-2025-0009","url":null,"abstract":"<p><strong>Background: </strong>The long-term immune and metabolic effects of COVID-19 in vaccinated populations remain incompletely characterized. This study aimed to analyze dynamic changes in lymphocyte subpopulations (T, B, and Natural Killer [NK] cells [TBNK]) and key metabolic indicators among college students post-Omicron infection with prior vaccination.</p><p><strong>Methods: </strong>A prospective observational cohort of 71 male students infected with the Omicron variant of COVID-19 (Beijing, China; March-April 2022) and 18 uninfected controls was followed for 2 years. TBNK subsets and metabolic parameters (uric acid, lipid profiles, β2-microglobulin) were analyzed at 3, 6, 12, and 24 months post-infection.</p><p><strong>Results: </strong>Immunologically, total lymphocytes were elevated at 3 months when compared with controls (<i>P</i> = 0.0063). Total T cells declined at 6 and 12 months but rebounded by 24 months (<i>P</i> < 0.0001). NK cells increased until 12 months, then declined (<i>P</i> < 0.0001). B cells decreased persistently (<i>P</i> < 0.05). Metabolically, uric acid and lipid parameters (total cholesterol, LDL-C, lipoprotein [a]) showed significant fluctuations, with notable increases at 1 year post-infection (<i>P</i> < 0.05). β2-microglobulin levels decreased significantly over time (<i>P</i> < 0.0001).</p><p><strong>Conclusion: </strong>Omicron infection induces immune and metabolic disturbances lasting at least 1 year, with gradual but incomplete recovery by 2 years. The interplay between immune dysregulation and metabolic alterations may contribute to the long-term health effects of COVID-19. Monitoring both lymphocyte and metabolic dynamics may guide the long-term management of post-COVID-19 sequelae.</p>","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"48 4","pages":"3-9"},"PeriodicalIF":0.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145913871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and validation of a deep vein thrombosis risk nomogram for post-operative complications in prostate cancer patients. 前列腺癌患者术后并发症的深静脉血栓形成风险图的开发和验证。
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 DOI: 10.3138/CIM-2025-0195
Dingqin Zheng

Background: Post-operative deep vein thrombosis (DVT) significantly compromises outcomes in prostate cancer (PCa) surgery patients. This study aimed to develop and validate a clinically applicable nomogram for individualized DVT risk stratification.

Methods: In this retrospective matched case-control study, 500 PCa patients (150 DVT, 350 non-DVT) undergoing surgery (2018-2023) were analyzed after rigorous DVT confirmation via duplex ultrasonography (92.2% adherence) and radiologist adjudication (κ = 0.86). To address the inflated DVT incidence due to case-control sampling, inverse probability weighting corrected sampling bias (weighted DVT incidence 12.3% versus true 12.1%), with post-weighting covariate balance confirmed by a standardized mean difference <0.08. Independent predictors were identified through multivariate logistic regression, with nomogram construction and validation (bootstrap optimism correction; temporal validation cohort n = 103). Decision curve analysis (DCA) evaluated clinical utility by quantifying net benefit across threshold probabilities (5%-80%).

Results: Age (OR 1.045 [95% CI 1.022-1.072] per year), surgery duration (OR 1.018/10 [95% CI 1.011-1.025 per min), preoperative D-dimer (OR 1.315 [95% CI 1.192-1.451] for every 0.1 mg/L), prostate-specific antigen density (PSAD; OR 4.805 [95% CI 2.761-8.365] per unit), and advanced tumour stage (T3-T4, OR 3.512 [95% CI 2.012-6.115]) were significant predictors. The nomogram demonstrated excellent discrimination (optimism-corrected area under the curve [AUC] = 0.942; temporal validation AUC=0.918) and calibration (slope = 0.94). Clinical thresholds: age ≥68.3 years, surgery ≥159.7 min, D-dimer ≥0.92 mg/L, PSAD ≥2.95 ng/mL/cm³. DCA revealed optimal clinical utility at 10%-60% risk thresholds, with a maximum net benefit (0.111) at 10% threshold probability, consistently outperforming default treatment strategies.

Conclusions: This validated nomogram integrates five readily available clinical variables to precisely quantify DVT risk in PCa surgical patients. It enables personalized preoperative risk assessment, facilitating targeted prophylaxis to mitigate thromboembolic complications beyond guideline-compliant prevention.

背景:前列腺癌(PCa)手术患者术后深静脉血栓(DVT)显著影响预后。本研究旨在开发和验证个体化DVT风险分层的临床应用nomogram。方法:在这项回顾性匹配病例对照研究中,对2018-2023年接受手术的500例PCa患者(150例DVT, 350例非DVT)进行分析,经双工超声严格确认DVT(92.2%依从性)和放射科医生判定(κ = 0.86)。为了解决病例对照抽样导致的DVT发生率虚高的问题,反概率加权校正了抽样偏差(加权DVT发生率12.3%对真实DVT发生率12.1%),加权后的协变量平衡通过标准化平均差异得到证实。结果:年龄(OR 1.045 [95% CI 1.022-1.072]每年)、手术时间(OR 1.018/10 [95% CI 1.011-1.025 /分钟)、术前d -二聚体(OR 1.315 [95% CI 1.192-1.451]每0.1 mg/L)、前列腺特异性抗原密度(PSAD;OR为4.805 [95% CI 2.761-8.365] /单位),肿瘤分期晚期(T3-T4, OR为3.512 [95% CI 2.012-6.115])是显著的预测因子。该模态图具有良好的判别性(曲线下乐观校正面积[AUC] = 0.942;时间验证AUC=0.918)和校准性(斜率= 0.94)。临床阈值:年龄≥68.3岁,手术≥159.7 min, d -二聚体≥0.92 mg/L, PSAD≥2.95 ng/mL/cm³。DCA在10%-60%的风险阈值下显示最佳临床效用,在10%的阈值概率下显示最大净收益(0.111),始终优于默认治疗策略。结论:这个经过验证的nomogram整合了5个现成的临床变量来精确量化PCa手术患者的DVT风险。它使个性化的术前风险评估,促进有针对性的预防,以减轻血栓栓塞并发症超出指南合规的预防。
{"title":"Development and validation of a deep vein thrombosis risk nomogram for post-operative complications in prostate cancer patients.","authors":"Dingqin Zheng","doi":"10.3138/CIM-2025-0195","DOIUrl":"https://doi.org/10.3138/CIM-2025-0195","url":null,"abstract":"<p><strong>Background: </strong>Post-operative deep vein thrombosis (DVT) significantly compromises outcomes in prostate cancer (PCa) surgery patients. This study aimed to develop and validate a clinically applicable nomogram for individualized DVT risk stratification.</p><p><strong>Methods: </strong>In this retrospective matched case-control study, 500 PCa patients (150 DVT, 350 non-DVT) undergoing surgery (2018-2023) were analyzed after rigorous DVT confirmation via duplex ultrasonography (92.2% adherence) and radiologist adjudication (κ = 0.86). To address the inflated DVT incidence due to case-control sampling, inverse probability weighting corrected sampling bias (weighted DVT incidence 12.3% versus true 12.1%), with post-weighting covariate balance confirmed by a standardized mean difference <0.08. Independent predictors were identified through multivariate logistic regression, with nomogram construction and validation (bootstrap optimism correction; temporal validation cohort n = 103). Decision curve analysis (DCA) evaluated clinical utility by quantifying net benefit across threshold probabilities (5%-80%).</p><p><strong>Results: </strong>Age (OR 1.045 [95% CI 1.022-1.072] per year), surgery duration (OR 1.018/10 [95% CI 1.011-1.025 per min), preoperative D-dimer (OR 1.315 [95% CI 1.192-1.451] for every 0.1 mg/L), prostate-specific antigen density (PSAD; OR 4.805 [95% CI 2.761-8.365] per unit), and advanced tumour stage (T3-T4, OR 3.512 [95% CI 2.012-6.115]) were significant predictors. The nomogram demonstrated excellent discrimination (optimism-corrected area under the curve [AUC] = 0.942; temporal validation AUC=0.918) and calibration (slope = 0.94). Clinical thresholds: age ≥68.3 years, surgery ≥159.7 min, D-dimer ≥0.92 mg/L, PSAD ≥2.95 ng/mL/cm³. DCA revealed optimal clinical utility at 10%-60% risk thresholds, with a maximum net benefit (0.111) at 10% threshold probability, consistently outperforming default treatment strategies.</p><p><strong>Conclusions: </strong>This validated nomogram integrates five readily available clinical variables to precisely quantify DVT risk in PCa surgical patients. It enables personalized preoperative risk assessment, facilitating targeted prophylaxis to mitigate thromboembolic complications beyond guideline-compliant prevention.</p>","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"48 4","pages":"10-22"},"PeriodicalIF":0.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145913818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Year in Review 2025. 2025年回顾。
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 DOI: 10.3138/CIM-48-4-Editorial
Brent W Winston
{"title":"Year in Review 2025.","authors":"Brent W Winston","doi":"10.3138/CIM-48-4-Editorial","DOIUrl":"https://doi.org/10.3138/CIM-48-4-Editorial","url":null,"abstract":"","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"48 4","pages":"1-2"},"PeriodicalIF":0.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145913797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investing in MD+ training to safeguard Canada's clinician-scientist workforce. 投资医学博士+培训,以保护加拿大的临床医生和科学家队伍。
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-09-01 DOI: 10.3138/CIM-48-3-Editorial
Robert T Moore, Trevor A Low, Karys M Hildebrand, Zahra Goodarzi
{"title":"Investing in MD+ training to safeguard Canada's clinician-scientist workforce.","authors":"Robert T Moore, Trevor A Low, Karys M Hildebrand, Zahra Goodarzi","doi":"10.3138/CIM-48-3-Editorial","DOIUrl":"https://doi.org/10.3138/CIM-48-3-Editorial","url":null,"abstract":"","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"48 3","pages":"1-2"},"PeriodicalIF":0.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145349809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiparametric echocardiography for predicting recovery in moderate to severe sepsis-associated acute respiratory distress syndrome: A retrospective study. 多参数超声心动图预测中至重度败血症相关急性呼吸窘迫综合征恢复:一项回顾性研究。
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-09-01 DOI: 10.3138/CIM-2025-0082
Shijuan Dun, Huaxue Wang, Jinmeng Chen, Jie Zhang, Kun Lu

Background: This study aimed to evaluate the predictive value of multiparametric transthoracic echocardiography (TTE) in patients with moderate to severe sepsis-associated acute respiratory distress syndrome (SA-ARDS), with a focus on right ventricular function and myocardial strain.

Methods: This single-centre retrospective cohort study was conducted at a tertiary academic medical centre. Data were collected for adult patients admitted to the ICU between June 2020 and June 2024, who developed sepsis within the first 24 hours of ICU admission.

Results: A total of 1,163 patients with moderate to severe SA-ARDS were included, with a mean age of 67.4 (SD 14.0) years. Diabetes and chronic lung disease were the most common comorbidities. Clinical predictors of non-recovery included severe ARDS (p = 0.003), and lower PaO₂/FIO₂ ratios (p < 0.001). In contrast, echocardiographic predictors of recovery included higher tricuspid annular plane systolic excursion (TAPSE) (p < 0.001) and lower right ventricular systolic pressure (RVSP) (p = 0.023), higher right ventricular fractional area change (RV-FAC) (p < 0.001), and more negative global longitudinal strain (GLS) (p < 0.001) compared to the non-recovery group. The combined model integrating RV-FAC, GLS, and right ventricular free wall longitudinal strain (RVFWLS) demonstrated superior predictive performance (area under the receiver operating characteristic curve (AUC) = 0.879 [95% CI 0.854-0.904]), outperforming traditional TTE parameters (TAPSE + RVSP, AUC = 0.783, p < 0.001).

Conclusion: Multiparametric echocardiography, particularly RV-FAC, GLS, and RVFWLS, provides a robust tool for predicting SA-ARDS recovery. These findings emphasize the critical role of right ventricular adaptability and myocardial deformation in prognosis.

背景:本研究旨在评估多参数经胸超声心动图(TTE)对中重度脓毒症相关急性呼吸窘迫综合征(SA-ARDS)患者的预测价值,重点关注右心室功能和心肌应变。方法:该单中心回顾性队列研究在某三级学术医疗中心进行。收集了2020年6月至2024年6月期间入住ICU的成年患者的数据,这些患者在入住ICU的前24小时内发生败血症。结果:共纳入1163例中重度SA-ARDS患者,平均年龄67.4岁(SD 14.0)。糖尿病和慢性肺病是最常见的合并症。未恢复的临床预测因子包括严重ARDS (p = 0.003)和较低的PaO₂/FIO₂比率(p < 0.001)。与未恢复组相比,超声心动图预测指标包括三尖瓣环平面收缩偏移(TAPSE)升高(p < 0.001)和右室收缩压(RVSP)降低(p = 0.023),右室分数面积变化(RV-FAC)升高(p < 0.001),整体纵向应变(GLS)负增加(p < 0.001)。结合RV-FAC、GLS和右心室自由壁纵向应变(RVFWLS)的联合模型显示出优越的预测性能(受试者工作特征曲线下面积(AUC) = 0.879 [95% CI 0.854-0.904]),优于传统的TTE参数(TAPSE + RVSP, AUC = 0.783, p < 0.001)。结论:多参数超声心动图,特别是RV-FAC、GLS和RVFWLS,为预测SA-ARDS恢复提供了强有力的工具。这些发现强调了右心室适应性和心肌变形在预后中的关键作用。
{"title":"Multiparametric echocardiography for predicting recovery in moderate to severe sepsis-associated acute respiratory distress syndrome: A retrospective study.","authors":"Shijuan Dun, Huaxue Wang, Jinmeng Chen, Jie Zhang, Kun Lu","doi":"10.3138/CIM-2025-0082","DOIUrl":"https://doi.org/10.3138/CIM-2025-0082","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to evaluate the predictive value of multiparametric transthoracic echocardiography (TTE) in patients with moderate to severe sepsis-associated acute respiratory distress syndrome (SA-ARDS), with a focus on right ventricular function and myocardial strain.</p><p><strong>Methods: </strong>This single-centre retrospective cohort study was conducted at a tertiary academic medical centre. Data were collected for adult patients admitted to the ICU between June 2020 and June 2024, who developed sepsis within the first 24 hours of ICU admission.</p><p><strong>Results: </strong>A total of 1,163 patients with moderate to severe SA-ARDS were included, with a mean age of 67.4 (SD 14.0) years. Diabetes and chronic lung disease were the most common comorbidities. Clinical predictors of non-recovery included severe ARDS (<i>p</i> = 0.003), and lower PaO₂/FIO₂ ratios (<i>p</i> < 0.001). In contrast, echocardiographic predictors of recovery included higher tricuspid annular plane systolic excursion (TAPSE) (<i>p</i> < 0.001) and lower right ventricular systolic pressure (RVSP) (<i>p</i> = 0.023), higher right ventricular fractional area change (RV-FAC) (<i>p</i> < 0.001), and more negative global longitudinal strain (GLS) (<i>p</i> < 0.001) compared to the non-recovery group. The combined model integrating RV-FAC, GLS, and right ventricular free wall longitudinal strain (RVFWLS) demonstrated superior predictive performance (area under the receiver operating characteristic curve (AUC) = 0.879 [95% CI 0.854-0.904]), outperforming traditional TTE parameters (TAPSE + RVSP, AUC = 0.783, <i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>Multiparametric echocardiography, particularly RV-FAC, GLS, and RVFWLS, provides a robust tool for predicting SA-ARDS recovery. These findings emphasize the critical role of right ventricular adaptability and myocardial deformation in prognosis.</p>","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"48 3","pages":"15-28"},"PeriodicalIF":0.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145349819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility of admission platelet count to predict prognosis and determine illness severity in acute cholangitis. 急性胆管炎患者入院血小板计数预测预后和确定病情严重程度的应用。
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-09-01 DOI: 10.3138/CIM-2025-0004
Xi Shi, Xueping Hou, Jinglun Liu, Shijing Tian, Jianrong Zhou, Xiaoying Chen

Introduction: Thrombocytopenia occurs frequently in patients with acute cholangitis and is considered a risk factor for poor prognosis. The present study aimed to investigate the relationship of thrombocytopenia with 60-day mortality and cholangitis disease severity.

Methods: This was a single-centre, retrospective, observational cohort study. We analyzed 498 patients with acute cholangitis who were admitted to our hospital between July 2013 and July 2021. The correlation between admission platelet count and disease severity and prognosis were analyzed.

Results: In this study, the incidence of thrombocytopenia (platelet count <100×109/L) and severe thrombocytopenia (platelet count <50×109/L) in acute cholangitis was 31.12% and 7.43%, respectively. Median platelet count in the thrombocytopenia group was 64×109/L (IQR 42, 79). Compared with the no-thrombocytopenia group, the thrombocytopenia group had a higher proportion of grade III cases, incidences of complications (including respiratory failure, circulatory failure, bacteremia), and higher Acute Physiologic Assessment and Chronic Health Evaluation (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores (all P < 0.05). The 60-day mortality rate was significantly higher in the thrombocytopenia group than that in the no-thrombocytopenia group (12.90% vs. 2.33%, P < 0.001). Binary logistic regression analysis demonstrated that platelet count on admission was a risk factor for mortality. Receiver operating characteristic (ROC) curve analysis showed 84×109/L as the optimal platelet count cut-off value for predicting 60-day mortality with acute cholangitis (Assessment area under the ROC curve [AUC] 0.79; sensitivity 76.4%, specificity 71.4%).

Conclusion: Platelet count is a readily available, prognostic marker that can identify acute cholangitis patients at risk of poorer outcomes.

急性胆管炎患者常发生血小板减少症,被认为是预后不良的危险因素。本研究旨在探讨血小板减少症与60天死亡率和胆管炎疾病严重程度的关系。方法:这是一项单中心、回顾性、观察性队列研究。我们分析了2013年7月至2021年7月住院的498例急性胆管炎患者。分析入院血小板计数与病情严重程度及预后的相关性。结果:本研究中急性胆管炎患者血小板减少(血小板计数9/L)和重度血小板减少(血小板计数9/L)的发生率分别为31.12%和7.43%。血小板减少组中位血小板计数为64×109/L (IQR 42,79)。与无血小板减少组相比,血小板减少组III级病例比例、并发症(包括呼吸衰竭、循环衰竭、菌血症)发生率、急性生理评估和慢性健康评估(APACHE II)和顺序器官衰竭评估(SOFA)评分均高于无血小板减少组(P < 0.05)。血小板减少组60天死亡率明显高于非血小板减少组(12.90% vs. 2.33%, P < 0.001)。二元logistic回归分析表明,入院时血小板计数是死亡率的危险因素。受试者工作特征(ROC)曲线分析显示,84×109/L为预测急性胆管炎60天死亡率的最佳血小板计数临界值(ROC曲线下评估面积[AUC] 0.79,敏感性76.4%,特异性71.4%)。结论:血小板计数是一种容易获得的预后指标,可以识别急性胆管炎患者预后不良的风险。
{"title":"Utility of admission platelet count to predict prognosis and determine illness severity in acute cholangitis.","authors":"Xi Shi, Xueping Hou, Jinglun Liu, Shijing Tian, Jianrong Zhou, Xiaoying Chen","doi":"10.3138/CIM-2025-0004","DOIUrl":"10.3138/CIM-2025-0004","url":null,"abstract":"<p><strong>Introduction: </strong>Thrombocytopenia occurs frequently in patients with acute cholangitis and is considered a risk factor for poor prognosis. The present study aimed to investigate the relationship of thrombocytopenia with 60-day mortality and cholangitis disease severity.</p><p><strong>Methods: </strong>This was a single-centre, retrospective, observational cohort study. We analyzed 498 patients with acute cholangitis who were admitted to our hospital between July 2013 and July 2021. The correlation between admission platelet count and disease severity and prognosis were analyzed.</p><p><strong>Results: </strong>In this study, the incidence of thrombocytopenia (platelet count <100×10<sup>9</sup>/L) and severe thrombocytopenia (platelet count <50×10<sup>9</sup>/L) in acute cholangitis was 31.12% and 7.43%, respectively. Median platelet count in the thrombocytopenia group was 64×10<sup>9</sup>/L (IQR 42, 79). Compared with the no-thrombocytopenia group, the thrombocytopenia group had a higher proportion of grade III cases, incidences of complications (including respiratory failure, circulatory failure, bacteremia), and higher Acute Physiologic Assessment and Chronic Health Evaluation (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores (all <i>P</i> < 0.05). The 60-day mortality rate was significantly higher in the thrombocytopenia group than that in the no-thrombocytopenia group (12.90% vs. 2.33%, <i>P</i> < 0.001). Binary logistic regression analysis demonstrated that platelet count on admission was a risk factor for mortality. Receiver operating characteristic (ROC) curve analysis showed 84×10<sup>9</sup>/L as the optimal platelet count cut-off value for predicting 60-day mortality with acute cholangitis (Assessment area under the ROC curve [AUC] 0.79; sensitivity 76.4%, specificity 71.4%).</p><p><strong>Conclusion: </strong>Platelet count is a readily available, prognostic marker that can identify acute cholangitis patients at risk of poorer outcomes.</p>","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"48 3","pages":"6-14"},"PeriodicalIF":0.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145349842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Newsletter Fall 2025: Clinician Investigator Trainee Association of Canada (CITAC). 2025年秋季通讯:加拿大临床研究员培训协会(CITAC)。
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-09-01 DOI: 10.3138/CIM-48-3-News
MohdWessam Al Jawhri, Naomi Catie Futhey, Richard Huang, YingQi Laetitia Wang, Salonee V Patel
{"title":"Newsletter Fall 2025: Clinician Investigator Trainee Association of Canada (CITAC).","authors":"MohdWessam Al Jawhri, Naomi Catie Futhey, Richard Huang, YingQi Laetitia Wang, Salonee V Patel","doi":"10.3138/CIM-48-3-News","DOIUrl":"https://doi.org/10.3138/CIM-48-3-News","url":null,"abstract":"","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"48 3","pages":"3-5"},"PeriodicalIF":0.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145349763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Cross-Sectional Study of the Relationship Between Low-Level Live Microbe Dietary Intake and Periodontitis among US Adults: Results from the NHANES 2009-2014. 美国成年人低水平活微生物饮食摄入与牙周炎关系的横断面研究:来自NHANES 2009-2014的结果。
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-06-01 DOI: 10.3138/cim-2024-0137
Xuming Wang, Xiaoli Ji

Background: The dietary intake of live microbes is inextricably linked to human health. The aim of this study was to investigate a potential relationship between low-level dietary live microbe (LDLM) intake and periodontitis.

Methods: According to the Sanders dietary live microbial classification system and the Centers for Disease Control and Prevention and American Academy of Periodontology periodontitis case definitions, this observational study included a total of 3,116 adults from the National Health and Nutrition Examination Survey (NHANES) database with complete periodontal data and LDLM intake. Univariate analysis, multivariable logistic regression analysis, and restricted cubic spline regression were performed to analyze the association between periodontitis and LDLM.

Results: After adjusting for all covariates, LDLM was found to be associated with periodontitis prevalence (P = 0.05 for trend) but not with periodontitis severity. The results of the restricted cubic spline analysis showed a non-linear relationship between LDLM and periodontitis prevalence (P = 0.05). Periodontitis prevalence was lowest with LDLM consumption of 2,923.89 g per day.

Conclusion: LDLM intake showed a statistically significant non-linear relationship with periodontitis prevalence, with the lowest prevalence of periodontitis at an intake of 2,923.89 g per day.

背景:活微生物的膳食摄入与人类健康有着千丝万缕的联系。本研究的目的是调查低水平饮食活微生物(LDLM)摄入与牙周炎之间的潜在关系。方法:根据Sanders膳食活微生物分类系统、疾病控制与预防中心和美国牙周病学会对牙周炎病例的定义,本观察性研究包括来自国家健康与营养检查调查(NHANES)数据库的3116名成年人,他们有完整的牙周数据和LDLM摄入量。采用单因素分析、多因素logistic回归分析和限制性三次样条回归分析牙周炎与LDLM的关系。结果:对所有协变量进行校正后,发现LDLM与牙周炎患病率相关(趋势P = 0.05),但与牙周炎严重程度无关。限制三次样条分析结果显示LDLM与牙周炎患病率呈非线性关系(P = 0.05)。牙周炎患病率最低的是每天消耗2,923.89 g LDLM。结论:LDLM摄入量与牙周炎患病率呈显著的非线性关系,摄入量为2923.89 g / d时牙周炎患病率最低。
{"title":"A Cross-Sectional Study of the Relationship Between Low-Level Live Microbe Dietary Intake and Periodontitis among US Adults: Results from the NHANES 2009-2014.","authors":"Xuming Wang, Xiaoli Ji","doi":"10.3138/cim-2024-0137","DOIUrl":"https://doi.org/10.3138/cim-2024-0137","url":null,"abstract":"<p><strong>Background: </strong>The dietary intake of live microbes is inextricably linked to human health. The aim of this study was to investigate a potential relationship between low-level dietary live microbe (LDLM) intake and periodontitis.</p><p><strong>Methods: </strong>According to the Sanders dietary live microbial classification system and the Centers for Disease Control and Prevention and American Academy of Periodontology periodontitis case definitions, this observational study included a total of 3,116 adults from the National Health and Nutrition Examination Survey (NHANES) database with complete periodontal data and LDLM intake. Univariate analysis, multivariable logistic regression analysis, and restricted cubic spline regression were performed to analyze the association between periodontitis and LDLM.</p><p><strong>Results: </strong>After adjusting for all covariates, LDLM was found to be associated with periodontitis prevalence (<i>P</i> = 0.05 for trend) but not with periodontitis severity. The results of the restricted cubic spline analysis showed a non-linear relationship between LDLM and periodontitis prevalence (<i>P</i> = 0.05). Periodontitis prevalence was lowest with LDLM consumption of 2,923.89 g per day.</p><p><strong>Conclusion: </strong>LDLM intake showed a statistically significant non-linear relationship with periodontitis prevalence, with the lowest prevalence of periodontitis at an intake of 2,923.89 g per day.</p>","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"48 2","pages":"21-28"},"PeriodicalIF":0.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144818140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The 2024 Henry G. Friesen International Prize in Health Research. 2024年亨利·g·弗里森国际健康研究奖。
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-06-01 DOI: 10.3138/cim-2025-guyatt
Shengjie Ying, Gordon Guyatt

[Table: see text].

[表:见正文]。
{"title":"The 2024 Henry G. Friesen International Prize in Health Research.","authors":"Shengjie Ying, Gordon Guyatt","doi":"10.3138/cim-2025-guyatt","DOIUrl":"https://doi.org/10.3138/cim-2025-guyatt","url":null,"abstract":"<p><p>[Table: see text].</p>","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"48 2","pages":"4-6"},"PeriodicalIF":0.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144818144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The CSCI Distinguished Scientist Award. CSCI杰出科学家奖。
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-06-01 DOI: 10.3138/cim-2025-tardif
Wenxuan Wang, Salonee V Patel, Jean-Claude Tardif

[Table: see text].

[表:见正文]。
{"title":"The CSCI Distinguished Scientist Award.","authors":"Wenxuan Wang, Salonee V Patel, Jean-Claude Tardif","doi":"10.3138/cim-2025-tardif","DOIUrl":"https://doi.org/10.3138/cim-2025-tardif","url":null,"abstract":"<p><p>[Table: see text].</p>","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"48 2","pages":"7-9"},"PeriodicalIF":0.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144818145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical and Investigative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1